- Patriot Act author on James Clapper: Fire, prosecute him
- Russia P.M. Medvedev: No amnesty for political prisoners
- Michigan GOP Senate hopeful reminds government is the ‘servant’
- Christmas, by Congress: Members mull a 15-cent tax on trees
- U.S. unemployment falls to five-year low of 7 percent; 203K jobs added
- World mourns Nelson Mandela and celebrates his life; burial set for Dec. 15
- Bill O’Reilly reminds: Nelson Mandela ‘was a communist’
- John Boehner says GOP should support gay candidates: ‘I do’
- Grass-Whopper: Pan-fried cricket burgers go over big in New York City
- CDC sees measles spike and ‘failure to vaccinate’
New changes aimed at improving transparency
BERLIN | Facebook Inc. has agreed to make several changes to its services to improve transparency and better protect the personal data of its millions of users outside of the U.S., following an in-depth audit of its international headquarters that was released Wednesday.
The social media company, based in Palo Alto, Calif., agreed to changes including asking European users if they wanted to partake in its Facial Recognition, reworking its policies of retaining and deleting private data, and reducing the amount of information collected about people who are not logged into Facebook, the company said in response to the report of the Irish Data Protection Commissioner.
Facebook’s international headquarters are based in Dublin. Ireland is a member of the European Union, meaning the company is required to comply with European data privacy laws, which are more stringent than those that apply in the United States, particularly regarding how long data can be retained.
The company has agreed to present its results in a follow-up to the report in July.
Judge upholds $327M verdict over J&J marketing
TRENTON | A South Carolina judge has upheld a $327 million civil penalty against Johnson & Johnson, which was found guilty by a jury of overstating the safety and effectiveness of antipsychotic drug Risperdal.
Attorneys for the state say it’s the biggest verdict in the country over the marketing of Risperdal.
The pill for schizophrenia and bipolar disorder once brought J&J more than $3.4 billion in annual sales.
But it’s been mired for years in litigation over alleged kickbacks, promotion for unapproved uses and other efforts to boost Risperdal over competing drugs. Dozens of pending state and federal cases allege illegal marketing practices for Risperdal, including one in which Texas is seeking up to $1 billion.
J&J of New Brunswick, N.J., says it will appeal the South Carolina ruling.
Apple buys startup for about $400M
© Copyright 2013 The Washington Times, LLC. Click here for reprint permission.
- Spike in battlefield deaths linked to restrictive rules of engagement
- Activists urge Obama to go rogue, sidestep Congress
- Bill OReilly reminds: Nelson Mandela was a communist
- PRUDEN: British press horrified as London's new mayor dares to proclaim the truth
- 'Hunger Games' delivers Obama's message on income inequality
- New battlefront emerges in war between Republicans, tea party
- U.S. pilot scares off Iranians with 'Top Gun'-worthy stunt: 'You really ought to go home'
- Obama administration issues permits for wind farms to kill more eagles
- Budget negotiators look to federal workers for benefit concessions
- Obama downplays IRS scandal, blames Obamacare rollout on 'outdated' agencies
Independent voices from the The Washington Times Communities
A politically conservative and morally liberal Hebrew alpha male hunts left-wing viper
This column will cover anything that has anything remotely to do with the game of baseball, from the game itself to mid-summer trades to offseason moves.
Entertainment News and Reviews from Washington, D.C. and beyond.
Political satirist and Christian apologist Bob Siegel discusses religion and politics.
White House pets gone wild!